Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System

Cytotherapy - Tập 16 - Trang 1048-1058 - 2014
Patrick J. Hanley1,2, Zhuyong Mei1, April G. Durett1, Marie da Graca Cabreira-Harrison3, Mariola Klis1, Wei Li1, Yali Zhao1, Bing Yang4, Kaushik Parsha4, Osman Mir4, Farhaan Vahidy4, Debra Bloom5, R. Brent Rice6, Peiman Hematti5, Sean I. Savitz4, Adrian P. Gee1
1Center for Cell and Gene Therapy, Texas Children's Hospital, The Methodist Hospital, and Baylor College of Medicine, Houston, Texas, USA
2Program for Cell Enhancement and Technologies for Immunotherapy, Sheikh Zayed Institute for Pediatric Surgical Innovation, and The Center for Cancer and Immunology Research, Children's National Medical Center, Washington, DC, USA
3The Texas Heart Institute, St Luke's Episcopal Hospital, Houston, Texas, USA
4Department of Neurology, University of Texas Health Science Center, Houston, Texas, USA
5University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA
6Terumo BCT, Lakewood, Colorado, USA

Tài liệu tham khảo

Uccelli, 2008, Mesenchymal stem cells in health and disease, Nature Rev Immunol, 8, 726, 10.1038/nri2395 Nauta, 2007, Immunomodulatory properties of mesenchymal stromal cells, Blood, 110, 3499, 10.1182/blood-2007-02-069716 Philippe, 2010, Culture and use of mesenchymal stromal cells in phase I and II clinical trials, Stem Cells Int, 2010, 503593, 10.4061/2010/503593 Newman, 2009, Treatment of inflammatory diseases with mesenchymal stem cells, Inflamm Allergy Drug Targets, 8, 110, 10.2174/187152809788462635 Horwitz, 2002, Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone, Proc Natl Acad Sci U S A, 99, 8932, 10.1073/pnas.132252399 Reiser, 2005, Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases, Exp Opin Biol Ther, 5, 1571, 10.1517/14712598.5.12.1571 Battiwalla, 2009, Mesenchymal stem cells in hematopoietic stem cell transplantation, Cytotherapy, 11, 503, 10.1080/14653240903193806 Campagnoli, 2001, Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow, Blood, 98, 2396, 10.1182/blood.V98.8.2396 Malgieri, 2010, Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art, Int J Clin Exp Med, 3, 248 Gotherstrom, 2003, Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells, Bone Marrow Transplant, 32, 265, 10.1038/sj.bmt.1704111 Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143 Vidal, 2012, Evaluation of senescence in mesenchymal stem cells isolated from equine bone marrow, adipose tissue, and umbilical cord tissue, Stem Cells Dev, 21, 273, 10.1089/scd.2010.0589 Connick, 2011, The Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments, Trials, 12, 62, 10.1186/1745-6215-12-62 Sabatino, 2012, The establishment of a bank of stored clinical bone marrow stromal cell products, J Translation Med, 10, 23, 10.1186/1479-5876-10-23 Hanley, 2013, Manufacturing mesenchymal stromal cells for phase I clinical trials, Cytotherapy, 15, 416, 10.1016/j.jcyt.2012.09.007 Bieback, 2011, Translating research into clinical scale manufacturing of mesenchymal stromal cells, Stem Cells Int, 2010, 193519 Sensebe, 2011, Good manufacturing practices production of mesenchymal stem/stromal cells, Hum Gene Ther, 22, 19, 10.1089/hum.2010.197 Horwitz, 1999, Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta, Nature Med, 5, 309, 10.1038/6529 Klyushnenkova, 2005, T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression, J Biomed Sci, 12, 47, 10.1007/s11373-004-8183-7 Nold, 2013, Good manufacturing practice-compliant animal-free expansion of human bone marrow derived mesenchymal stroma cells in a closed hollow-fiber-based bioreactor, Biochem Biophys Res Commun, 430, 325, 10.1016/j.bbrc.2012.11.001 Rojewski, 2012, GMP-compliant isolation and expansion of bone marrow-derived MSCs in the closed, automated device Quantum Cell Expansion system, Cell Transplant, 22, 1981, 10.3727/096368912X657990 Schallmoser, 2009, Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures, J Visual Exp, 32, 1523 Friedenstein, 1974, Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method, Exp Hematol, 2, 83 Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement, Cytotherapy, 8, 315, 10.1080/14653240600855905 Schallert, 2000, CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury, Neuropharmacology, 39, 777, 10.1016/S0028-3908(00)00005-8 Pileggi, 2012, Mesenchymal stem cells for the treatment of diabetes, Diabetes, 61, 1355, 10.2337/db12-0355 Lee, 2010, A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke, Stem Cells, 28, 1099, 10.1002/stem.430 Jean-Francois Michiels, 2013, Scaling up stem cells: utilizing a multiplate bioreactor to preserve the integrity of the culture, Genet Eng Biotechnol News, 33, 26, 10.1089/gen.33.2.17 Jones, 2013, Genetic stability of bone marrow-derived human mesenchymal stromal cells in the Quantum System, Cytotherapy, 15, 1323, 10.1016/j.jcyt.2013.05.024 Otsuru, 2013, Improved isolation and expansion of bone marrow mesenchymal stromal cells using a novel marrow filter device, Cytotherapy, 15, 146, 10.1016/j.jcyt.2012.10.012